Zai Lab ZLAB
NASDAQ ZLAB
$26.23 -0.77 (-2.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zai Lab (ZLAB) Cash from Investing Activities (2018 - 2026)

Zai Lab (ZLAB) posted Cash from Investing Activities of -$22.3 million for Q1 2026, down 97.31% sequentially from -$11.3 million in Q4 2025, and down 106.83% YoY from $326.1 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Zai Lab has reported Cash from Investing Activities for 9 years, with the latest figure at -$22.3 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 106.83% year-over-year to -$22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.6 million (up 22.53% YoY) and the FY2025 annual result came in at $307.9 million, up 182.06% from the prior year.
  • Cash from Investing Activities declined to -$22.3 million in Q1 2026 per ZLAB's latest filing, from -$11.3 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $568.3 million in Q3 2022 and troughed at -$347.8 million in Q4 2024.
  • A 5-year average of $18.8 million and a median of -$4.4 million in 2022 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 2622.65% in 2022, then jumped 9806.83% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$4.4 million in 2022, then jumped by 430.6% to $14.5 million in 2023, then plunged by 2505.44% to -$347.8 million in 2024, then jumped by 96.75% to -$11.3 million in 2025, then sank by 97.31% to -$22.3 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$22.3 million, -$11.3 million, and -$4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn -1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.42 Mn
Mar 31, 2026 -22.29 Mn
Dec 31, 2025 -11.30 Mn
Sep 30, 2025 -4.05 Mn
Jun 30, 2025 -2.92 Mn
Mar 31, 2025 326.13 Mn
Dec 31, 2024 -347.75 Mn
Sep 30, 2024 -29.89 Mn
Jun 30, 2024 -846,000.00
Mar 31, 2024 3.29 Mn
Dec 31, 2023 14.46 Mn
Sep 30, 2023 -13.98 Mn
Jun 30, 2023 42.70 Mn
Mar 31, 2023 -53.95 Mn
Dec 31, 2022 -4.37 Mn
Sep 30, 2022 568.26 Mn
Jun 30, 2022 -113.73 Mn
Mar 31, 2022 -30.14 Mn
Dec 31, 2021 -281.49 Mn
Sep 30, 2021 -206.38 Mn